Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics
- Sponsor
- Tianjin Central Hospital of Gynecology Obstetrics
- Study ID
- NCT06753734
- Status
- Enrolling By Invitation
Conditions
- Gestational Diabetes
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Accepted
Study Details
This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.
Key Dates
- First listed
- Dec 31, 2024
- Start date
- Dec 25, 2024
- Status verified
- Dec 2024
- Primary completion
- Mar 31, 2026
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 600 participants (estimated)
Arms
- Arm: Gestational Diabetes Group
- Arm: control group
Primary Outcome Measure
Incidence of gestational diabetes mellitus [ Time Frame: 24-28 weeks gestation ]
Related Studies
- Immediate Postpartum Glucose Tolerance TestingRecruiting · MemorialCare Health System · Long Beach, California
- iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational DiabetesRecruiting · The University of Texas Health Science Center, Houston · Houston, Texas
- DETERMINE: Detemir vs NPHPHASE2 · Recruiting · University of California, Los Angeles · Los Angeles, California
- Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesRecruiting · Indiana University · Birmingham, Alabama